©The Author(s) 2025.
World J Cardiol. Nov 26, 2025; 17(11): 110178
Published online Nov 26, 2025. doi: 10.4330/wjc.v17.i11.110178
Published online Nov 26, 2025. doi: 10.4330/wjc.v17.i11.110178
Table 2 Comparison of clinical outcomes between aspirin and non-aspirin groups
| Outcome | Aspirin (n = 90) | No aspirin (n = 233) | P value | OR (95%CI) |
| ICU admission | 16.7% | 28.8% | 0.025 | 0.496 (0.266-0.924) |
| Shock | 2.2% | 9.9% | 0.021 | 0.208 (0.048-0.899) |
| RV strain (CT) | 22.2% | 34.8% | 0.029 | 0.536 (0.305-0.944) |
| In-hospital mortality | 3.3% | 11.6% | 0.022 | 0.260 (0.080-0.889) |
| Mechanical ventilation | 6.7% | 4.7% | 0.483 | 1.442 (0.517-4.021) |
| EKOS therapy | 3.3% | 11.2% | 0.047 | 0.275 (0.081-0.931) |
| Cardiac arrest | 6.7% | 6.0% | 0.826 | 1.117 (0.416-3.004) |
- Citation: Suresh MG, Mohamed S, Shanmugavel Geetha H, Sekar A, Prabhu S, Sargent J, Abraham GM, Hatwal J, Batta A, Mohan B. Prehospital aspirin use is associated with improved clinical outcomes in pulmonary embolism: A retrospective case-control study. World J Cardiol 2025; 17(11): 110178
- URL: https://www.wjgnet.com/1949-8462/full/v17/i11/110178.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i11.110178